Search by Drug Name or NDC
NDC 42543-0407-01 POTASSIUM CITRATE 10 meq/1 Details
POTASSIUM CITRATE 10 meq/1
POTASSIUM CITRATE is a ORAL TABLET in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Strides Pharma Inc.. The primary component is POTASSIUM CITRATE.
MedlinePlus Drug Summary
Potassium is essential for the proper functioning of the heart, kidneys, muscles, nerves, and digestive system. Usually the food you eat supplies all of the potassium you need. However, certain diseases (e.g., kidney disease and gastrointestinal disease with vomiting and diarrhea) and drugs, especially diuretics ('water pills'), remove potassium from the body. Potassium supplements are taken to replace potassium losses and prevent potassium deficiency. This medication is sometimes prescribed for other uses; ask your doctor or pharmacist for more information.
Related Packages: 42543-0407-01Last Updated: 11/30/2022
MedLinePlus Full Drug Details: Potassium
Product Information
| NDC | 42543-0407 |
|---|---|
| Product ID | 42543-407_67ba2683-6fb5-429e-ab39-6f004ac33f1b |
| Associated GPIs | 56202010200440 |
| GCN Sequence Number | 017000 |
| GCN Sequence Number Description | potassium citrate TABLET ER 10 MEQ ORAL |
| HIC3 | R1S |
| HIC3 Description | URINARY PH MODIFIERS |
| GCN | 14951 |
| HICL Sequence Number | 000548 |
| HICL Sequence Number Description | POTASSIUM CITRATE |
| Brand/Generic | Generic |
| Proprietary Name | POTASSIUM CITRATE |
| Proprietary Name Suffix | EXTENDED RELEASE |
| Non-Proprietary Name | POTASSIUM CITRATE |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | TABLET |
| Route | ORAL |
| Active Ingredient Strength | 10 |
| Active Ingredient Units | meq/1 |
| Substance Name | POTASSIUM CITRATE |
| Labeler Name | Strides Pharma Inc. |
| Pharmaceutical Class | Acidifying Activity [MoA], Anti-coagulant [EPC], Calcium Chelating Activity [MoA], Calculi Dissolution Agent [EPC], Decreased Coagulation Factor Activity [PE] |
| DEA Schedule | n/a |
| Marketing Category | ANDA |
| Application Number | ANDA206813 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 42543-0407-01 (42543040701)
| NDC Package Code | 42543-407-01 |
|---|---|
| Billing NDC | 42543040701 |
| Package | 100 TABLET in 1 BOTTLE (42543-407-01) |
| Marketing Start Date | 2017-11-01 |
| NDC Exclude Flag | N |
| Pricing Information | |
| Price Per Unit | 0.28601 |
| Pricing Unit | EA |
| Effective Date | 2024-02-21 |
| NDC Description | POTASSIUM CITRATE ER 10 MEQ TB |
| Pharmacy Type Indicator | C/I |
| OTC | N |
| Explanation Code | 1 |
| Classification for Rate Setting | G |
| As of Date | 2024-02-21 |
This pricing file, entitled the NADAC (National Average Drug Acquisition
Cost) files, provide
state Medicaid agencies with covered outpatient drug prices by averaging
survey invoice
prices from retail community pharmacies across the United States. These
pharmacies include
independent retail community pharmacies and chain pharmacies. The prices
are updated on a
weekly and monthly basis